Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 1, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to corporate governance disclosures regarding share ownership.
Material Changes
On October 29, 2004, the GlaxoSmithKline Employee Trust (GSK Trust) transferred 20,336 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on November 1, 2004.
Outlook and Risks
The filing contains no management commentary, financial guidance, risk factors, or contingencies. It notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries.
Investor Verification Points
- Confirm the total number of shares held by the GSK Trust following the transfer of 20,336 shares.
- Verify the specific shareholding changes for directors Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe as beneficiaries of the trust.
- Review the terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand the vesting conditions for the transferred shares.